JP2004000128A5 - - Google Patents

Download PDF

Info

Publication number
JP2004000128A5
JP2004000128A5 JP2002331107A JP2002331107A JP2004000128A5 JP 2004000128 A5 JP2004000128 A5 JP 2004000128A5 JP 2002331107 A JP2002331107 A JP 2002331107A JP 2002331107 A JP2002331107 A JP 2002331107A JP 2004000128 A5 JP2004000128 A5 JP 2004000128A5
Authority
JP
Japan
Prior art keywords
gene
hematopoietic tumor
expression
shp1
alleles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002331107A
Other languages
English (en)
Other versions
JP2004000128A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002331107A priority Critical patent/JP2004000128A/ja
Priority claimed from JP2002331107A external-priority patent/JP2004000128A/ja
Publication of JP2004000128A publication Critical patent/JP2004000128A/ja
Publication of JP2004000128A5 publication Critical patent/JP2004000128A5/ja
Pending legal-status Critical Current

Links

Description

したがって、本発明では、ＳＨＰ１遺伝子の発現を、遺伝子ＤＮＡの修飾とｍＲＮＡと蛋白質と対立遺伝子の喪失という最大で四重のマーカーを用いて判定できることになる。すなわち、ＳＨＰ１遺伝子の発現低下という一つの造血器腫瘍細胞特異的な現象を４段階で確認することができるため、非常に高い特異性で造血器腫瘍細胞を検出することができる。
JP2002331107A 2002-04-05 2002-11-14 造血器腫瘍細胞検出方法および造血器腫瘍細胞検出キット Pending JP2004000128A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002331107A JP2004000128A (ja) 2002-04-05 2002-11-14 造血器腫瘍細胞検出方法および造血器腫瘍細胞検出キット

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002103495 2002-04-05
JP2002331107A JP2004000128A (ja) 2002-04-05 2002-11-14 造血器腫瘍細胞検出方法および造血器腫瘍細胞検出キット

Publications (2)

Publication Number Publication Date
JP2004000128A JP2004000128A (ja) 2004-01-08
JP2004000128A5 true JP2004000128A5 (ja) 2005-04-14

Family

ID=30446682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002331107A Pending JP2004000128A (ja) 2002-04-05 2002-11-14 造血器腫瘍細胞検出方法および造血器腫瘍細胞検出キット

Country Status (1)

Country Link
JP (1) JP2004000128A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080070240A2 (en) * 2004-04-08 2008-03-20 Toyo Boseki Kabushiki Kaisha Composition for deaminating dna and method of detecting methylated dna
US9556430B2 (en) * 2005-05-27 2017-01-31 Dana-Farber Cancer Institute, Inc. Gene methylation and expression
EP2034029B1 (en) 2006-06-16 2013-02-27 National University Corporation Okayama University Test method for malt lymphoma and kit therefor

Similar Documents

Publication Publication Date Title
DE60144517D1 (de) Rekombinante konstrukte und ihre verwendung bei der reduzierung der genexpression
Xie et al. TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma
NO20081925L (no) Genekspresjonprofilering for identifisering av prognostiske underklasser i nasofaryngale karsinomer
DK1597391T3 (da) Anvendelse af intron-RNA til måling af genekspression
DK1106696T3 (da) Proteindeamiderende enzym, mikroorganisme producerende dette, gen kodende derfor, fremgangsmåde til fremstilling af enzymet og anvendelse deraf
DK1576170T3 (da) Nukleinsyrer og tilsvarende proteiner med betegnelsen 191p4d12(b), der kan anvendes i behandling og påvisning af cancer
NO20022359D0 (no) Inhibering av genekspresjon med dsRNA
SI1546174T1 (sl) Metode in sestavki za rna interferenco
WO2006071466A8 (en) Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
IL177326A0 (en) Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
BRPI0510475B8 (pt) adenovírus quimérico recombinante, uso do mesmo no tratamento de câncer e métodos de inibição de crescimento de uma célula de câncer, de fornecimento de uma proteína terapêutica a uma célula e para o isolamento do adenovírus
MXPA04012614A (es) Xilanasas, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
JP2007512807A5 (ja)
WO2007135568A3 (en) A METHOD FOR PREDICTING RESPONSIVENESS TO TNFα BLOCKING AGENTS
DE502005008373D1 (de) Polymorphismen im nod2/card15 gen
AU2003259285A1 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
WO2007002031A3 (en) Dna polymerase blends and mutant dna polymerases
WO2005087948A3 (en) Cancer treatment and assays for determining resistance to platinum-based chemotherapeutic agent
WO2005080578A3 (en) Desaturase enzymes
JP2004000128A5 (ja)
AU2003276868A8 (en) Cloning and characterization of the broad-spectrum resistance gene pi2
BR112012030647A2 (pt) substrato destinado a servir de suporte de cultura e aplicação à realização notadamente de superfícies desportivas
IL146970A0 (en) Migration of haematopoietic stem cells and progenitor cells to the liver
EP1452595A4 (en) ES CELLS WITH REINFORCED RNAI EFFECT
WO2007016210A3 (en) Methylation markers for prognosis and treatment of cancers